VOLIMED M3 Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
VOLIMED M3 Tablet should be taken just before a meal. The dose and how often you need it will be decided by your doctor so that you get the right amount to control your blood sugar levels. Do not stop taking it suddenly without consulting your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness.
This medicine is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Monitor your blood sugar levels regularly while taking this medicine.
The most common side effects of VOLIMED M3 Tablet include flatulence (gas), stomach pain, loss of appetite, constipation, and diarrhea. Consult your doctor if any of these side effects bother you or do not go away. This medicine by itself does not cause hypoglycemia (low blood sugar levels). However, when used in combination with other diabetes medicines (especially insulin or sulphonylureas), it can lead to hypoglycemia (low blood sugar levels). Such episodes of hypoglycemia will have to be treated by taking plain glucose. Table sugar or common sugar will not help correct low blood sugar levels if you are taking this medicine.
Before taking it, let your doctor know if you have any kidney or liver problems. Do not take this medicine if you have ulceration or inflammation in the bowel (eg. ulcerative colitis or Crohn’s disease). Pregnant or breastfeeding women should also consult their doctor before taking it. Please tell your doctor about all the other medicines you are taking to make sure you are safe. Avoid excessive alcohol intake while taking this medicine as it may increase the risk of hypoglycemia (low blood sugar levels).
Reviews
There are no reviews yet.